After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production
Is Merck (MRK) stock still a buy after losing the vaccine race?
Categories
pharmaceuticals
LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges posed by
SmileDirectClub (SDC) bets on rapid telemedicine-adoption to drive growth
The adoption of telemedicine accelerated in recent months, especially after the pandemic-related shelter-in-place orders came into effect. The trend will likely continue
SmileDirectClub (SDC) Q1 Report: Net loss narrows but misses estimates
Digital healthcare firm SmileDirectClub Inc. (NASDAQ: SDC) reported a narrower net loss for the first quarter of 2021 amid modest revenue growth.
Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic
Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported Q1 revenue
AbbVie (ABBV) Stock: Here’s what you need to know before investing
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's flagship product
Vertex Pharmaceuticals Inc (VRTX) Q1 2021 Earnings Call Transcript
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations
Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic
Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results
Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9% to $3.98
Johnson & Johnson (JNJ) reports Q1 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Two areas that provide Pfizer (PFE) with ample opportunity for future growth
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront of the
It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical programs to
Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues?
The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy in the
Walgreens Boots Alliance Inc. (WBA) Q2 2021 Earnings Call
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of Investor Relations
Here’s what you need to know before investing in Amgen (AMGN)
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely successful. While
Walgreens Boots Alliance, Inc. (WBA) Q2 2021 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President of Investor
Walgreens Boots Alliance (WBA) Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second-quarter 2021 earnings results today. Sales increased 4.6% to $32.8 billion. It is up 3.5%
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete
These two factors will play out in favor of Pfizer (PFE) going forward
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past 12 months. The company had a huge win with
Abbott’s (ABT) stock can give high returns, thanks to COVID-related tailwinds
The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services. However, in